How do I interpret my Gleason score or Ki-67 for Prostate Cancer

Prostate CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Gleason Score and Ki-67 for Prostate Cancer

Great question—these are two important markers that help your oncology team understand your prostate cancer and guide treatment decisions. Let me break down what each one means.

Gleason Score: How Aggressive Is Your Cancer?

Your Gleason score is a grading system that describes how abnormal your cancer cells look under a microscope compared to normal prostate tissue.

How it works:

  • Pathologists (doctors who examine tissue samples) assign a grade of 1-5 to the two most common patterns of cancer cells they see
  • These two grades are added together to create your Gleason score (ranging from 2-10)
  • Higher scores = more aggressive-looking cancer cells

What the scores generally mean:

| Score | What It Suggests | |-------|------------------| | 6 or less | Low-grade (slower-growing, less aggressive appearance) | | 7 | Intermediate-grade (moderate aggressiveness) | | 8-10 | High-grade (more aggressive appearance, faster potential growth) |

Important context: A higher Gleason score doesn't automatically mean your cancer will spread quickly—it's one piece of information your doctor uses alongside other factors like PSA level, stage, and your overall health.


Ki-67: How Fast Are Cells Dividing?

Ki-67 is a protein marker that measures how many cancer cells are actively dividing (multiplying) at any given time. Think of it as a "cell activity meter."

How it works:

  • Pathologists use a special stain to identify cells with Ki-67 protein
  • The result is reported as a percentage (e.g., 15%, 40%, 60%)
  • Higher percentage = more cells actively dividing = potentially faster-growing cancer

What the percentages generally mean:

| Ki-67 Level | What It Suggests | |-------------|-----------------| | Low (under 10%) | Slower cell division, generally less aggressive | | Intermediate (10-30%) | Moderate cell division rate | | High (over 30%) | Rapid cell division, more aggressive behavior |


How Doctors Use These Together

Your oncology team considers both markers as part of the bigger picture:

  • Gleason score = structure/appearance of cancer cells
  • Ki-67 = activity level of cancer cells
  • Together with PSA level, stage, and your age/health, they help determine:
    • How closely to monitor you
    • Whether treatment is needed now or if active surveillance is appropriate
    • Which treatment approach might work best

Questions to Ask Your Oncologist

Since your specific situation requires your doctor's evaluation, here are targeted questions to help you understand YOUR results:

  1. "What is my specific Gleason score, and what does that mean for my cancer's behavior?"

  2. "What is my Ki-67 percentage, and how does it compare to typical values?"

  3. "Considering both my Gleason score and Ki-67, what risk category do I fall into (low, intermediate, or high-risk)?"

  4. "How do these results influence your recommendation for treatment versus active surveillance?"

  5. "Are there any other biomarkers or tests you'd recommend to get a complete picture of my cancer?"


Important Context About These Markers

According to clinical practice, these markers are most useful when interpreted together with:

  • Your PSA level and PSA velocity (how fast it's rising)
  • Clinical stage (how far the cancer has spread)
  • Your age and overall health
  • Imaging results (MRI, bone scan if applicable)

Your oncologist weighs all these factors to create a personalized treatment plan. No single number tells the whole story.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Related Services

Services that may help with general for Prostate Cancer patients

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: